Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

  • Showing results for ali, abdullah. Your search for Ali Alabdullah retrieved no results.
1.

Dehydration affects drug transport over nasal mucosa.

Ali A, Wahlgren M, Rembratt-Svensson B, Daftani A, Falkman P, Wollmer P, Engblom J.

Drug Deliv. 2019 Dec;26(1):831-840. doi: 10.1080/10717544.2019.1650848.

PMID:
31401887
2.

Use of Routine Health Information System Data to Evaluate Impact of Malaria Control Interventions in Zanzibar, Tanzania from 2000 to 2015.

Ashton RA, Bennett A, Al-Mafazy AW, Abass AK, Msellem MI, McElroy P, Kachur SP, Ali AS, Yukich J, Eisele TP, Bhattarai A.

EClinicalMedicine. 2019 Jun 21;12:11-19. doi: 10.1016/j.eclinm.2019.05.011. eCollection 2019 Jul.

3.

Human behaviour and residual malaria transmission in Zanzibar: findings from in-depth interviews and direct observation of community events.

Monroe A, Mihayo K, Okumu F, Finda M, Moore S, Koenker H, Lynch M, Haji K, Abbas F, Ali A, Greer G, Harvey S.

Malar J. 2019 Jul 1;18(1):220. doi: 10.1186/s12936-019-2855-2.

4.

Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies.

Borot F, Wang H, Ma Y, Jafarov T, Raza A, Ali AM, Mukherjee S.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11978-11987. doi: 10.1073/pnas.1819992116. Epub 2019 May 28. Erratum in: Proc Natl Acad Sci U S A. 2019 Jul 16;116(29):14780-14781.

5.

Evaluating Response Time in Zanzibar's Malaria Elimination Case-Based Surveillance-Response System.

Khandekar E, Kramer R, Ali AS, Al-Mafazy AW, Egger JR, LeGrand S, Mkali HR, McKay M, Ngondi JM.

Am J Trop Med Hyg. 2019 Feb;100(2):256-263. doi: 10.4269/ajtmh.17-0546.

PMID:
30526729
6.

A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission.

Morris U, Msellem MI, Mkali H, Islam A, Aydin-Schmidt B, Jovel I, Shija SJ, Khamis M, Ali SM, Hodzic L, Magnusson E, Poirot E, Bennett A, Sachs MC, Tarning J, Mårtensson A, Ali AS, Björkman A.

BMC Med. 2018 Dec 10;16(1):215. doi: 10.1186/s12916-018-1202-8.

7.

Improving Treatment for Myelodysplastic Syndromes Patients.

Montoro J, Yerlikaya A, Ali A, Raza A.

Curr Treat Options Oncol. 2018 Oct 25;19(12):66. doi: 10.1007/s11864-018-0583-4. Review.

PMID:
30362079
8.

Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes.

Ali AM, Huang Y, Pinheiro RF, Xue F, Hu J, Iverson N, Hoehn D, Coutinho D, Kayani J, Chernak B, Lane J, Hillyer C, Galili N, Jurcic J, Mohandas N, An X, Raza A.

Blood Adv. 2018 Jun 26;2(12):1393-1402. doi: 10.1182/bloodadvances.2018018440.

9.

Survey and evaluation of mutations in the human KLF1 transcription unit.

Gnanapragasam MN, Crispino JD, Ali AM, Weinberg R, Hoffman R, Raza A, Bieker JJ.

Sci Rep. 2018 Apr 26;8(1):6587. doi: 10.1038/s41598-018-24962-3.

10.

The nuclear DEK interactome supports multi-functionality.

Smith EA, Krumpelbeck EF, Jegga AG, Prell M, Matrka MM, Kappes F, Greis KD, Ali AM, Meetei AR, Wells SI.

Proteins. 2018 Jan;86(1):88-97. doi: 10.1002/prot.25411. Epub 2017 Nov 11.

11.

Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar.

Ali AS, Thawer NG, Khatib B, Amier HH, Shija J, Msellem M, Al-Mafazy AW, Garimo IA, Mkali H, Ramsan MM, Kafuko JM, Paxton LA, Reithinger R, Ngondi JM.

Malar J. 2017 Aug 14;16(1):332. doi: 10.1186/s12936-017-1982-x.

12.

Spatial Distribution of Falciparum Malaria Infections in Zanzibar: Implications for Focal Drug Administration Strategies Targeting Asymptomatic Parasite Carriers.

Björkman A, Cook J, Sturrock H, Msellem M, Ali A, Xu W, Molteni F, Gosling R, Drakeley C, Mårtensson A.

Clin Infect Dis. 2017 May 1;64(9):1236-1243. doi: 10.1093/cid/cix136.

13.

DEK is required for homologous recombination repair of DNA breaks.

Smith EA, Gole B, Willis NA, Soria R, Starnes LM, Krumpelbeck EF, Jegga AG, Ali AM, Guo H, Meetei AR, Andreassen PR, Kappes F, Vinnedge LM, Daniel JA, Scully R, Wiesmüller L, Wells SI.

Sci Rep. 2017 Mar 20;7:44662. doi: 10.1038/srep44662.

14.

The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.

Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Bartels DB, Lip GY; GLORIA-AF Investigators.

J Am Coll Cardiol. 2017 Feb 21;69(7):777-785. doi: 10.1016/j.jacc.2016.11.061.

15.

Field Evaluation of a High Throughput Loop Mediated Isothermal Amplification Test for the Detection of Asymptomatic Plasmodium Infections in Zanzibar.

Aydin-Schmidt B, Morris U, Ding XC, Jovel I, Msellem MI, Bergman D, Islam A, Ali AS, Polley S, Gonzalez IJ, Mårtensson A, Björkman A.

PLoS One. 2017 Jan 17;12(1):e0169037. doi: 10.1371/journal.pone.0169037. eCollection 2017.

16.

Two different "tales" of ATG7: Clinical relevance to myelodysplastic syndromes.

Ali AM, Raza A.

Mol Cell Oncol. 2016 Jul 26;3(5):e1212686. eCollection 2016.

17.

Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.

Obeng EA, Chappell RJ, Seiler M, Chen MC, Campagna DR, Schmidt PJ, Schneider RK, Lord AM, Wang L, Gambe RG, McConkey ME, Ali AM, Raza A, Yu L, Buonamici S, Smith PG, Mullally A, Wu CJ, Fleming MD, Ebert BL.

Cancer Cell. 2016 Sep 12;30(3):404-417. doi: 10.1016/j.ccell.2016.08.006.

18.

U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3' End Formation.

Park SM, Ou J, Chamberlain L, Simone TM, Yang H, Virbasius CM, Ali AM, Zhu LJ, Mukherjee S, Raza A, Green MR.

Mol Cell. 2016 May 19;62(4):479-90. doi: 10.1016/j.molcel.2016.04.011. Epub 2016 May 12.

19.

Acute Uncomplicated Febrile Illness in Children Aged 2-59 months in Zanzibar - Aetiologies, Antibiotic Treatment and Outcome.

Elfving K, Shakely D, Andersson M, Baltzell K, Ali AS, Bachelard M, Falk KI, Ljung A, Msellem MI, Omar RS, Parola P, Xu W, Petzold M, Trollfors B, Björkman A, Lindh M, Mårtensson A.

PLoS One. 2016 Jan 28;11(1):e0146054. doi: 10.1371/journal.pone.0146054. eCollection 2016.

20.

The Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndrome.

Pang R, Ali A.

Transl Androl Urol. 2015 Dec;4(6):653-61. doi: 10.3978/j.issn.2223-4683.2015.08.10. Review.

Supplemental Content

Loading ...
Support Center